Nissan Medical Industries Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	640.72	664.08	733.91	684.65	668.37	721.48
Revenue Growth (YoY)	-10.98%	-9.52%	7.20%	2.44%	-7.36%	19.16%
Cost of Revenue	567.95	566.06	598.14	601.37	523.95	540.03
Gross Profit	72.77	98.02	135.78	83.28	144.42	181.45
Selling, General & Admin	66.78	68.35	73.14	85.19	78.54	71.21
Other Operating Expenses	-0.01	-0.01	1.26	-0.15	0.07	-0.1
Operating Expenses	66.78	68.35	74.4	85.04	78.61	71.11
Operating Income	5.99	29.68	61.37	-1.77	65.81	110.34
Interest Expense	-12.36	-13.34	-21.27	-10.02	-7.28	-9.39
Interest & Investment Income	0.55	0.47	0.18	0.01	-	0.09
Earnings From Equity Investments	2.32	1.3	-7.06	-0.64	4.62	10.66
Currency Exchange Gain (Loss)	2.74	1.51	0.05	-8.33	3.19	-1.06
Other Non Operating Income (Expenses)	-4.46	-4.46	-5.47	-2.44	-1.28	-1.3
EBT Excluding Unusual Items	-5.21	15.15	27.81	-23.18	65.06	109.33
Impairment of Goodwill	-	-	-	-23.79	-	-
Gain (Loss) on Sale of Investments	0	0	0.01	-0.05	5.39	0.68
Pretax Income	-1.21	15.15	27.82	-47.02	70.45	110.01
Income Tax Expense	-0.96	1.35	8.78	0.27	13.29	17.12
Earnings From Continuing Operations	-0.25	13.8	19.04	-47.29	57.16	92.89
Minority Interest in Earnings	0.25	-5.9	-13.39	11.24	-21.14	-36.04
Net Income	0	7.91	5.65	-36.05	36.01	56.85
Net Income to Common	0	7.91	5.65	-36.05	36.01	56.85
Net Income Growth	-100.00%	39.95%	-	-	-36.65%	261.87%
Shares Outstanding (Basic)	9	9	9	9	9	9
Shares Outstanding (Diluted)	9	9	9	9	9	9
EPS (Basic)	0.00	0.87	0.62	-3.97	3.96	6.26
EPS (Diluted)	-0.00	0.87	0.62	-3.97	3.93	6.26
EPS Growth	-	39.90%	-	-	-37.13%	261.87%
Free Cash Flow	15.51	20.74	95.9	2.49	9.82	108.71
Free Cash Flow Per Share	1.78	2.28	10.56	0.28	1.08	11.97
Dividend Per Share	1.820	0.750	-	-	0.440	1.000
Dividend Growth	142.67%	-	-	-	-56.00%	-
Gross Margin	11.36%	14.76%	18.50%	12.16%	21.61%	25.15%
Operating Margin	0.94%	4.47%	8.36%	-0.26%	9.85%	15.29%
Profit Margin	0.00%	1.19%	0.77%	-5.27%	5.39%	7.88%
Free Cash Flow Margin	2.42%	3.12%	13.07%	0.36%	1.47%	15.07%
EBITDA	28.28	53	86.9	26.88	91.4	137.76
EBITDA Margin	4.41%	7.98%	11.84%	3.93%	13.68%	19.09%
D&A For EBITDA	22.29	23.32	25.52	28.65	25.6	27.42
EBIT	5.99	29.68	61.37	-1.77	65.81	110.34
EBIT Margin	0.94%	4.47%	8.36%	-0.26%	9.85%	15.29%
Effective Tax Rate	-	8.92%	31.56%	-	18.87%	15.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.